• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Capitol Hill

Medicaid expansion tied to increase in prescriptions for diabetes drugs, birth control

April 20, 2017 By Sarah Faulkner

Prescription drugs

The number of prescriptions filled by adults using Medicaid rose 19% in states that expanded Medicaid compared to states that did not under the Affordable Care Act, according to a new study from the Harvard T.H. Chan School of Public Health. The largest increases were for drugs that help patients deal with chronic conditions, including […]

Filed Under: Diabetes, Featured, Pharmaceuticals, Policy Tagged With: Capitol Hill, Harvard University

Short of votes, Trumpcare bill is withdrawn

March 24, 2017 By Fink Densford

capitol hill

Republican leaders in the US House of Representatives today withdrew the GOP-backed Trumpcare bill, which aimed to begin dismantling and replacing Obamacare, due to a shortage of votes. A vote on the measure was planned after Trump cut off negotiations with Republicans who had balked at the plan and issued an ultimatum to vote on […]

Filed Under: Business/Financial News Tagged With: Capitol Hill

Drug importation bills aim to improve access, lower costs for Americans

March 20, 2017 By Sarah Faulkner

capitol hill

Members of the U.S. House and Senate have introduced bills that would allow Americans to import prescription drugs from Canada in an attempt to increase accessibility and lower the cost of drugs. Sens. Bernie Sanders (I-Vermont), Cory Booker (D-N.J.) and Bob Casey (D-Penn.) introduced the “Affordable and Safe Prescription Drug Importation Act” at the end […]

Filed Under: Featured, Pharmaceuticals, Policy, Wall Street Beat Tagged With: Capitol Hill

Trump’s pick for FDA chief faces questions over ties to drug industry

March 14, 2017 By Sarah Faulkner

FDA

Although President Donald Trump’s nominee for FDA commissioner has won approval from lawmakers across the aisle, he is facing questions from consumer watchdog Public Citizen over his ties to the drug industry that will likely arise during his confirmation hearings. The Medical Device Manufacturer Association has voiced its approval for Scott Gottlieb, saying “Dr. Gottlieb is a […]

Filed Under: Featured, Food & Drug Administration (FDA), Wall Street Beat Tagged With: Capitol Hill

Senate confirms Verma to head CMS as debate intensifies over Obamacare replacement

March 14, 2017 By Sarah Faulkner

capitol hill

The U.S. Senate voted yesterday 55-43 to confirm Seema Verma to head the Centers for Medicare and Medicaid Services. Verma is the founder & CEO of SVC Inc, a healthcare consulting firm, and worked with now-Vice President Mike Pence when he was governor of Indiana to redesign the state’s Medicaid program. Get the full story […]

Filed Under: Featured, Policy, Wall Street Beat Tagged With: Capitol Hill, Centers for Medicare and Medicaid Services (CMS)

Trump calls for speedier approval process, while Sanders takes aim at drug prices

March 1, 2017 By Sarah Faulkner

Capitol Hill

In his 1st address to Congress, President Donald Trump called for speeding up drug approvals within the FDA. Earlier that day, Sen. Bernie Sanders (I-Vermont) proposed a bill to allow the importation of prescription drugs from Canada in the hopes of lowering drug prices. The new administration has been critical of drug prices, with Trump saying that […]

Filed Under: Featured, Food & Drug Administration (FDA), Policy, Wall Street Beat Tagged With: Capitol Hill

Democratic senators float bill to protect ‘scientific integrity’

February 10, 2017 By Sarah Faulkner

capitol hill

Sen. Bill Nelson (D-Fla.) introduced a bill this week that aims to protect and promote ‘scientific integrity’. The legislation builds on policies from former President Barack Obama’s 2009 executive order, which required federal agencies to define how they planned to safeguard scientific integrity. The bill, which has 27 co-signers and has been referred to the Committee […]

Filed Under: Featured, Policy, Research & Development, Wall Street Beat Tagged With: Capitol Hill

Senators question Kaleo over pricey opioid overdose device

February 10, 2017 By Sarah Faulkner

Kaleo

In a letter signed by 30 U.S. senators, Sen. Claire McCaskill (D-Missouri) asked Kaleo Pharmaceutical to explain the 550% price hike for its Evzio opioid overdose device. The company’s product, which Kaleo sold for $690 in 2014, is priced at $4,500. Evzio is a naloxone auto-injector designed to reverse the effects of an opioid overdose. It can […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Capitol Hill, Kaleo Inc

Senate confirms Price as HHS chief

February 10, 2017 By Sarah Faulkner

capitol hill

The Senate confirmed Rep. Tom Price (R-Ga.) to head the Health & Humans Services Dept. in a 52-47 vote early this morning. No Democratic senator voted to support the new administration’s nominee, but he was passed through in the Republican-majority Senate. Democrats spent hours last night protesting his confirmation, pushing the vote until 2 A.M. […]

Filed Under: Policy, Wall Street Beat Tagged With: Capitol Hill

Sens. Sanders, Cruz talk drug pricing, Obamacare in town hall debate

February 8, 2017 By Sarah Faulkner

Capitol Hill

Sens. Bernie Sanders (I-Vermont) and Ted Cruz (R-Texas) met last night to debate the future of Obamacare in a town-hall debate. The 2 senators are opposed on how to provide health care coverage to Americans, but found common ground on drug pricing and pharmaceutical importation. Sanders and Cruz agreed that people should be able to […]

Filed Under: Featured, Food & Drug Administration (FDA), Pharmaceuticals Tagged With: Capitol Hill

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS